VeerleBossuytMD

Pathology • Boston, MA

Cytopathology, Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology, Yale University School of Medicine

Join to view full profile

Dr. Bossuyt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bossuyt's full profile

Already have an account?

Office
55 Fruit St
Boston, MA 02114
Phone+1 617-726-2967

Education & Training

Brigham and Women's HospitalFellowship, Cytopathology, 2006 - 2007
Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 2002 - 2005
Vrije Universiteit BrusselsClass of 2002

Certifications & Licensure

MA State Medical License 2005 - 2025
NH State Medical License 2023 - 2025
CT State Medical License 2007 - 2019
American Board of Pathology Anatomic Pathology
American Board of Pathology Cytopathology

Publications & Presentations

PubMed

233 citations
Immunological differences between primary and metastatic breast cancer.
Borbála Székely, Veerle Bossuyt, Xiaotong Li, Vikram B. Wali, G Patwardhan
Annals of Oncology. 2018-11-01
177 citations
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer : recommendations from an international working...
Elena Provenzano, Veerle Bossuyt, Giuseppe Viale, David Cameron, Sunil V. Badve
Modern Pathology. 2015-07-24
2 citations
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer.
Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T Coates, Bogang Wu
Clinical Cancer Research. 2024-07-15

Press Mentions

Evaluating Post-Treatment Breast SpecimensJanuary 20th, 2023